Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 33Pain, Postoperative 4Chronic Pain 3Neoplasms 2Lymphoma, Non-Hodgkin 2Lung Neoplasms 2Breast Diseases 2Brain Neoplasms 2Agnosia 2Vulvodynia 1Uterine Cervical Neoplasms 1Skin Diseases 1Seroma 1Recurrence 1Radiation Injuries 1Postoperative Hemorrhage 1Peripheral Nervous System Diseases 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms by Site 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Hot Flashes 1Hodgkin Disease 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Gangliosidosis, GM1 1Gangliosidoses 1

Interventions

Trastuzumab 5Carboplatin 5Docetaxel 4pertuzumab 3Paclitaxel 3Cyclophosphamide 3pembrolizumab 2Epirubicin 2Doxorubicin 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1trebananib 1trastuzumab duocarmazine 1taxane 1talazoparib 1sarilumab 1pyrotinib 1pirarubicin 1pexidartinib 1patritumab 1olaparib 1niraparib 1neratinib 1ganitumab 1durvalumab 1dostarlimab 1cemiplimab 1abemaciclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Sodium Chloride × Breast × Clear all
NCT04781725 2021-11-17

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

Ottawa Hospital Research Institute

Phase 2 Unknown
90 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡